TNNI3 and cardiovascular disorder: In a study by Li et al. [131], they introduced an integrated microfluidic platform (IMS) designed for swift measurement of biomarkers associated with cardiovascular diseases (NT-proBNP, fibrinogen, cTnI, and CRP).